Infectious Diseases Society of America

a. Administrative positions:

• 
  Organizing committee of the 8th International Pathogenic Neisseria Conference, October 1992, Cuernavaca, Mexico
  
• 
  Coordinator of the IV National AIDS Conference, October 1993, Mexico City, Mexico
  
• 
  Organizing committee of the IV International Conference on Travel Medicine, April 1995, Acapulco, Mexico
  
• 
  Coordinator of the V National AIDS Conference, November 1995, Mexico City, Mexico
  
• 
  Scientific Committee, 1^st IAS Conference on HIV Pathogenesis and Treatment, Buenos Aires, Argentina, July 2001
  
• 
  Track Co-chair, 2001 National HIV Prevention Conference, Atlanta, GA, August 2001
  
• 
  Scientific Program Committee Member, 3^rd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants. Kampala, Uganda. September 2001.
  
• 
  International Scientific Committee, XIV International Conference on AIDS, Barcelona, Spain, July 2002
  
• 
  Scientific Program Committee member, 8^th World STI/AIDS Congress, Punta del Este, Uruguay, December 2-5, 2003.
  
• 
  Joint Program Committee Track Co-chair, XVI International Conference on AIDS, Mexico City, Mexico, August 2008.
  
• 
  Track Co-chair, 2009 National HIV Prevention Conference, Atlanta, GA, August 2009
  
• 
  Planning Committee Member, 36^th Remington Winter Course in Infectious Diseases. Vail, CO. February 21 - 26, 2010
  
• 
  Co-Chair, AIDS Vaccine 2010. Atlanta, GA. September 28 – October 1, 2010
  
• 
  Regional Chair, HIVDART2010. Los Cabos, Mex. December 7 – 10, 2010
  
• 
  Planning Committee Member, 37^th Remington Winter Course in Infectious Diseases. Snowmass, CO. February 6 – 11, 2011
  
• 
  Member, Clinical Science Track Committee, XIX International Conference on AIDS, Washington, DC. July 22 – 27, 2012
  
• 
  Member, Scientific Advisory Committee, 2^nd International Treatment as Prevention (TasP) Workshop. Vancouver, BC. April 22 – 25, 2012
  
• 
  Member, Scientific Advisory Committee, 3^rd International Treatment as Prevention (TasP) Workshop. Vancouver, BC. April 22 – 25, 2013
  
• 
  
  

My research efforts focus on access to care, linkage to care and barriers to care among HIV-infected hard to reach populations in the United States. I also do research on treatment and prevention of HIV/AIDS as well as adherence and the impact of therapy on behavior. Finally, I am interested in the spectrum and impact of AIDS in developing countries and issues related to access to care in resource poor settings.

a. Active support:

Federally funded:

1. 
   NIH (2P30 AI 50409-10). Emory CFAR. (PI: JW. Curran, Co-PI C. del Rio) 08/01/07 – 7/31/17.
   

• 
  NIH (D43 TW01042-11). Emory AIDS International Training and Research Program (PI: C. del Rio), 06/01/09 - 03/31/14.
  
• 
  CDC (1H25PS001412-01). Current Trends in Gonococcal Antimicrobial Resistance - GISP (PI: C. del Rio), 01/01/09 - 12/31/13.
  
• 
  NIH (D43 TW007124). Emory-Georgia Tuberculosis Research Training Program (PI: H. Blumberg; Co-PI: C. del Rio), 09/30/04 - 06/30/14.
  
• 
  NIH/NIDA (1RO1DA032098). Project Retain: Providing Integrated Care for HIV-infected crack cocaine users (co-PIs: L. Metsch & C. del Rio), 07/15/2011 – 04/30/2016.
  
• 
  NIH/NIDA (3U10DA013720-12S2). CTN049 – Project HOPE (PI’s L. Metsch & C. del Rio), 09/01/2011 – 08/31/2015
  
• 
  NIH/NIDA (5U10DA013720). Florida Node of the Drug Abuse Clinical Trials Network (PI: J. Szapocznik & L. Metsch; Local PI: C del Rio) 00/30/2000 – 08/31/2015
  
• 
  NIH/NIAID (AI069418). Emory HIV Clinical Trials Unit. (PI: J. Lennox; CRS leader and HPTN PI: C. del Rio ) 12/1/06 – 11/30/13
  
• 
  NIH/NIAID (HHSN27220080005). Vaccine and Treatment Evaluation Units (PI: M. Mulligan) 11/01/07 – 10/13/14
  
• 
  NIH/NIDA (RO1 DA29512-02). Public Housing relocations: Impact on HIV risk, drug use and healthcare access. (PI: H. Cooper & L. Bonney). 8/01/10 – 7/31/14
  
• 
  NIH/NIMH (RO1 MH0856001-A2). Explaining differences in HIV prevalence and incidence between black and white MSM (PI: P. Sullivan) 7/16/09 – 5/31/14
  
• 
  NIH/FIC (1R24TW008825-01). Emory-Ethiopia Global Interdisciplinary Partnership (PI: C. del Rio). 9/01/10 – 8/31/11
  
• 
  NIH/NIAID (R01 AI094575). Comprehensive HIV Prevention Package for MSM in Southern Africa (PI: P. Sullivan) 03/01/2011 – 02/28/2015
  
• 
  Manila Consulting Group, Inc. Evaluation of Rapid HIV Self-Testing among MSM in High Prevalence Cities, 09/16/2011 – 09/15/2015
  

b. Previous Support:

• 
  World AIDS Foundation, “A Confidential HIV/AIDS Counseling and Testing Center in Tbilisi, Georgia” (PI’s: del Rio, C and Tsertsvadze, T) 10/1/97 - 9/30/99. $100,000.
  
• 
  NIH (MH58077 RO1), Clinical and Psychological influences on HIV therapy (PI: Rothenberg, R.B., Co-PI: del Rio C.) 10/1/97 - 9/30/00. $322,893 (per year)
  
• 
  NIH (R01 AI 43586-02), Environmental and Molecular Epidemiology of P. carinii (PI: Vermund, S.) 09/30/99 - 04/30/01. Amount: $57,317.
  
• 
  CDC (UR3/CCU416463-02-02), An Assessment of the Acceptability of a Rapid HIV Test in an underserved population. (PI: del Rio, C). 09/30/99 – 09/29/01. Amount: $697,274.
  
• 
  EMCF, An Investigation to Determine the Molecular Epidemiology and Significance of Mycobacterium avium Complex Isolates from Respiratory Specimens at Grady Memorial Hospital. 03/01/98 – 02/28/99. Amount: $21,672.
  

• 
  NIH (P30 DA 12121-01). Emory/Atlanta CFAR Clinical Core (CFAR PI: Curran, JW; Core Director: del Rio C.) 01/01/98 - 12/31/02. Amount: $224,646 (total for clinical core)
  

• 
  NIH. The Potential for Medical Transmission of HIV in Ethiopia: International Research Collaboration. (PI: del Rio, C). 09/30/01 – 09/29/03 ($106,775)
  
• 
  NIH (D43 TW01042-01). Emory AIDS International Training and Research Program (PI: del Rio, C), 09/30/98 - 05/31/04. Amount: $310,064 (per year)
  
• 
  NIH (1RO1 DA13895 01). Persons without HAART: Characteristics and Determinants (PI: del Rio C.), 9/30/00 – 8/31/04. Amount: $395,870 (per year)
  
• 
  CDC (U64/CCU417657-03), An Intervention to enhance the transition from HIV diagnosis to Treatment (PI: del Rio, C.) CDC, 09/30/99 - 09/29/04. Amount: $230,317 (per year)
  
• 
  InterMune Pharmaceuticals, Inc. “A Randomized, Double Blind, Placebo-Controlled, Dose-Ranging, Phase II Study of the Safety and Antifungal Activity of Subcutaneous Recombinant Interferon (rIFN-y 1b) in Conjunction with Standard Therapy in Patients with Acute Cryptococal Meningitis”
  
• 
  AI464-025. Randomized Study of BMS-284756 for Complicated Skin and Soft Tissue Infections.
  
• 
  NIH/NIAID (2 U01 AI32775-06) AIDS Adult Clinical Trail Group (PI: Saag at UAB, Lennox at Emory), 2/1/96 – 11/30/06. Amount: $3,867,451
  
• 
  NIH (2P30 AI 50409-04A1). Emory CFAR. (PI: JW. Curran, Co-PI C. del Rio) 08/01/02 – 7/31/07. Amount $1,500,000 (per year)
  
• 
  CDC Foundation Young Investigator award: Development of a New HIV Prevention Device for Women (PI: Dr. Frances Priddy ; mentor: del Rio), 4/01/05 – 3/31/08
  

• 
  Merck 023: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase II Proof-of-Concept Study to Evaluate the Safety and Efficacy of a 3-Dose Regimen of the Merck Adenovirus Serotype 5 HIV-1 Vaccine gag/pol/nef (MRKAd5 HIV-1gag/pol/nef) in Adults at High Risk of HIV-1 Infection (PI: del Rio), 1/13/05 – 1/13/11
  

• 
  Sanofi-Pasteur: Randomized Controlled Double-Blind Trial Of The Comparative Viremia, Immunogenicity And Safety Of A 17-D Live Attenuated Yellow Fever Vaccine (YF-VAX®) Given Alone Or In Combination With Human Immune Globulin (Baygam®) (PI: del Rio), 1/06 – 12/09
  
• 
  NIH/NIDA (RO1 DA017612-1A2). Prevention among HIV+ Crack Users in the Hospital (PI: L. Metsch; Co-PI: C. del Rio), 06/06/2005 – 05/31/2010
  
• 
  CRDF (GEB1-002725-TB-07). Risk Factors for Anti-tuberculosis Drug-Induced Hepatotoxicity. (PI: H. Blumberg) 03/01/07 – 03/31/10
  
• 
  CRDF (GEB1-002939-TB-08). Latent TB Infection (LTBI) among HIV infected individuals in Georgia. (PI: C. del Rio) 06/01/09 – 05/31/11
  

• 
  The development of the “HIV continuum of care team” which has as its major goals to link clinical services between the hospital and the outpatient clinic. This has decreased length of hospital stay for HIV-infected patients at Grady and has improved follow-up in the outpatient clinic.
  
• 
  As Chief of the Medical Service at Grady Memorial Hospital I reorganized the service to provide more efficient and high quality care to the patients. I have also championed the implementation of clinical pathways to decrease length of stay, establish a department Quality Committee and improved billing and collections.
  

• 
  PBL Preceptor for M2’s (1998 – 2008)
  
• 
  M1 Patient-Doctor Course (1998 – 2000)
  
• 
  Medical Microbiology lecturer (STD Clinical Correlation and HIV Clinical Correlation)
  
• 
  Junior Medicine Clerkship lecturer
  
• 
  Special Curriculum Project in HIV/AIDS Education & Care for M1 Students
  
• 
  Medical Spanish elective for M2 students
  
• 
  CRC Mentor in MD/PhD Program
  

2. 
   Graduate Program:
   
   • 
     Morning report faculty for medical residents and interns (1998 – 2009)
     
   • 
     Various lectures to residents and ID fellows throughout the year (1997 – present)
     
   • 
     “Kokko Conference” A weekly unknown case discussion presented by the Medical Residents and voted several times as the “Best Conference in the Department of Medicine” (2001 – present)
     
   • 
     Emory Annual Board Review in Internal Medicine (1998 – present)
     

2. 
   Other categories
   

• 
  Lecturer in the Allied Health Pharmacology course (Course Director: David B. Glass, PhD)
  
• 
  Lecturer at the Rollins School of Public Health in the MPH program:
  
• 
  GH563: HIV/AIDS – Public Health Implications (Course Director: Dr. Susan Allen).
  
• 
  GH550: Epidemiology and dynamics of Sexually Transmitted Diseases (Course Director: Dr. Richard Rothenberg)
  
• 
  GH511: International Infectious Diseases: Control and Prevention (Course Director: Carlos del Rio)
  
• 
  GH590R: Vaccines and vaccine preventable diseases (Course Director: Saad Omer)
  
• 
  BIOS520M: Clinical Trial Design, Conduct and Analysis (Course directors: Beau B. Bruce and Andi Shane)
  

• 
  SHARE Course on HIV/AIDS. This course is given annually in Latin American during the Panamerican Infectious Diseases Society Meeting as part of a joint collaboration of the International AIDS Society and the Emory AITRP. (Approximately 100 people attend each year)
  
• 
  Symposium on HIV/AIDS. This course is given annually in Mexico as part of a joint collaboration of the Mexican Association of Microbiology and Infectious Diseases and the Emory AITRP. (Approximately 400 people attend each year)
  
• 
  In collaboration with the National Institute of Public Health in Mexico (INSP) the Emory AITRP conducts an annual “Diplomado en SIDA” (Diplomate on HIV/AIDS) which brings together for a one month intensive training on AIDS, decision makers and investigators from all over Mexico.
  

a. MPH students directly supervised (Thesis Advisor):

• 
  Lorraine N. Alexander, MPH. Graduated 1999 with Thesis “Missed Opportunities for the Diagnosis of HIV Infection in an Inner-City Hospital”
  
  • 
    Currently: Epidemiologist, National Immunization Program, Centers for Disease Control and Prevention. Atlanta, GA.
    
• 
  Giselle C. Hicks, MPH. Graduated 2001 with thesis “Patients’ Health Literacy as a Predictor of HIV/AIDS Knowledge Level”
  
  • 
    Currently: Clinical Trials Intern, Food and Drug Administration, Washington DC.
    
• 
  Lev Zohrabian, MD, MPH. Graduated 2001 with thesis “The Fall of the Former Soviet Union and its Impact on AIDS and Other Public Health Problems in Armenia (1995-2000)”
  
  • 
    Health Care Analyst IV, Contractor, TRW, Prevention Research S Project, Behavioral Intervention Research Branch, Division of AIDS Prevention, NCHSTP, Center for Diseases Control and Prevention.
    
• 
  Maribel Barragan, MPH. Graduated 2001 with Thesis “Health Literacy as a Determinant of HIV Testing”
  
  • 
    Currently: Project Coordinator, Emory University School of Medicine
    
• 
  Paul Petraro, MPH. Graduated 2002 with thesis “Persistent Occurrence of Pneumocystis carinni Despite Availability and Access to HAART in an inner-city population in the US”
  
  • 
    Currently: Data Manager, NASH Program, Centers for Disease Control and Prevention.
    
• 
  Carlos Franco-Paredes, MD, MPH. Graduated 2002 with thesis “Routinely Recommending HIV Testing at a Large Urgent Care Center: Assessing an “opt-out” strategy with Standard vs. Rapid HIV Testing”.
  

• 
  He is currently Assistant Professor of Medicine at Emory University School of Medicine.
  

• 
  Javier Romo-Garcia, MD, MsCR, Graduated 2003 with thesis “Risk Factors for Death in HIV patients with Extrapulmonary Tuberculosis”.
  

• 
  He is currently Chief of the HIV Outpatient Clinic at the National Institute of Lung Diseases (INER) in Mexico City, Mexico.
  

• 
  Kate E. Koplan, MD, MPH, Graduated 2004 with thesis “Bone Resorption and Dietary Calcium Consumption in Pregnant Women in Mexico City: Implications for Public Health Policy”.
  

• 
  She is attending physician at Brigham and Women’s Hospital, Boston, Mass.
  

• 
  Colleen Kelley, MD, MPH, Graduated 2004 with thesis “The Clinical and Epidemiologic Characteristics of Foreign-born Latinos at an Urban HIV Clinic”.
  

• 
  She is currently Assistant Professor of Medicine (Infectious Diseases) at Emory University, Atlanta, GA.
  

• 
  Nino Gabelia, MD, MPH, Graduated 2004 with thesis “Risk Factors for Hepatitis C Virus Infection among Intravenous Drug Users in the Republic of Georgia”.
  

• 
  She is currently International Health Officer with the US DHHS Office of Global Health Affairs in Washington, DC
  

• 
  Phuong Thi Mingh Pham, MD, MPH, Graduated 2004 with thesis “STD surveillance linked with HIV surveillance in Haiphonh City, Vietnam”
  

• 
  She is currently a clinician-researcher in the National Institute for Dermato-Venerology in Hanoi, Vietnam.
  

• 
  Akaki Turkia, MD, MPH, Graduated 2004 with thesis “Prevalence of Hepatitis B and C in the Republic of Georgia and risk factors for their transmission”
  

• 
  He is currently a clinical research associate with Quintiles.
  

• 
  Ekatarine Shapatava, MPH, Graduated 2004 with thesis “Risky behavioral factors related to the transmission of HIV, hepatitis B and hepatitis C among injecting drug users in Georgia”
  

• 
  She is currently a research interviewer with the Department of Behavioral Sciences and Health Education at Emory University’s Rollins School of Public Health.
  

• 
  Daniela Rodriguez, MPH, Graduated 2005 with thesis “Effective use of HIV/AIDS Surveillance Data: A qualitative assessment of barriers to data utilization in Mexican State Programs”
  
  • 
    She is currently a research project coordinator with Emory University.
    
• 
  Taitu Hailu, MPH, Graduated 2005 with thesis “Clinical Presentations Associated with HIV Infection at the Federal Police Hospital in Addis Ababa, Ethiopia between 1990 – 2004”
  

• 
  She is currently a candidate for a PhD in epidemiology at McGill University, Canada
  

• 
  Tadessech Hailu, MPH, Graduated 2005 with thesis “An Assessment of the Demographic Characteristics Associated with Testing HIV Positive at the Federal Police Hospital in Addis Ababa, Ethiopia between 1990 – 2004”
  

• 
  She is currently a candidate for a PhD in epidemiology at McGill University, Canada
  

• 
  Duc Bui Nguyen, MD, MSc, Graduated 2006 with thesis “Evaluation of the Adherence to cotrimoxazole prophylaxis of patients at CDC/LIFE-GAP outpatient clinics in Hanoi, Vietnam”
  

• 
  He is currently working for CDC/GAP in Vietnam
  

• 
  Hong Thi-Thu Nguyen, MPH, Graduated 2006 with thesis “Successes and Barriers to the Implementation of Anonymous Voluntary HIV Counseling and Testing in Vietnam: Evaluating Utilization of Services Provided Through LIFE-GAP Project”
  

• 
  She is currently working for CDC/GAP in Vietnam
  

• 
  Archil Undilashvili, MD, MPH, Graduated 2006 with thesis “The Epidemiology and HIV Risk Behaviors among Pregnant Women in the Republic of Georgia”
  

• 
  He is currently obtaining his MBA at Georgia State
  

• 
  Elisa Zaragoza, MD, MPH, Graduated 2007 with thesis “Predictors of Success to Highly Active Antiretroviral Therapy in an Antiretroviral Naïve Urban Population”
  

• 
  She is currently a Cardiology fellow at U. Washington
  

• 
  Justin M. Shuster, BA, MPH, Graduated 2007 with thesis “The Cultural and Community-level Acceptance of Antiretroviral Therapy Among Traditional Healers in Lukhanji, South Africa”
  

• 
  He is currently a research project coordinator at the Hope Clinic of the Emory Vaccine Center
  

• 
  Shelene K. Poetker, BS. (Emory Medical Student in the Class of 2009).
  

• 
  She is currently a medicine resident at the Brigham
  

• 
  Elyse Lafond (Emory College Student in the Class of 2010). Supervisor in her Directed study in Sociology (SOC 494R)
  
  • 
    She is currently a Research Project Coordinator at Emory University
    
• 
  Maria Alejandra Esteves-Jaramillo, MD, MPH, Graduated 2010 with thesis “Utility of a Facilitated Consent for Human Immunodeficiency Viru-1 (HIV-1) rapid testing among pregnant women in a Perinatal Center in Mexico City”
  

• 
  She is currently working for the “Centro para la Salud para la Infancia y la Adolescencia” of the Secretary of Health in Mexico
  

• 
  Hoang Huy Vu, MD, MPH, Graduated 2010 with thesis “Anemia among HIV-infected patients in Vietnam: Prevalence, severity and associated factors”
  

• 
  He is currently working for the PEPFAR/SAMHSA Team in Vietnam
  

• 
  Rafael Veraza-Bravo, B.S., MPH, Graduated 2011 with thesis “Peer effects and sexual risk behavior among Mexican migrants, non-migrants, and returning migrants”
  
  • 
    He is currently working for the CDC/WHO with the STOP Program in Botswana.
    
• 
  Lindsay Boole, MD, MPH, Graduated 2011 with thesis “Behavioral factors associated with engagement in high risk sex among urban, HIV-infected crack users in the Southeast United States”
  
  • 
    She is currently a PGY-1 medicine resident at Duke University.
    
• 
  Meghan Griffin, BS, MPH, Graduated 2011 with thesis “A tale of two countries: The HIV epidemic in Georgia and Ukraine, two countries of the Former Soviet Union”
  

b. Post-doctoral fellows directly supervised:

• 
  Miguel Cashat, MD, MSc (graduated from Emory December 2000)
  
  • 
    Currently: Medical Director of Antiviral Therapy for Merck and Co. in Mexico City, MEX
    

1. 
   Wayne Duffus, MD, PhD (Postdoctoral fellow in the Division of Infectious Diseases, EUSM from 1999 - 2002).
   

• 
  Currently State Health Officer, Columbia South Carolina.
  

2. 
   Carlos Franco-Paredes, MD (Postdoctoral fellow in the Division of Infectious Diseases EUSM and Emory AITRP fellow from 1999 – 2002).
   

• 
  Currently Assistant Professor of Medicine at Emory University School of Medicine.
  

3. 
   Erik Folch, MD (AITRP fellow, EUSM from 2000 - 2002).
   

• 
  Currently pulmonary and critical care fellow at the Cleveland Clinic
  

4. 
   Maria Isabel Hernandez, MD (AITRP fellow, EUSM 2000 - 2003).
   

• 
  Currently research associate at the National Institute of Public Health in Cuernavaca, Mexico
  

5. 
   Javier Romo-Garcia, MD (AITRP Fellow, EUSM 2001 – 2003).
   
6. 
   Aurora Vicas, MD, MPH. (Medicine Resident, EUSM).
   

• 
  Vicas AE, del Rio C, Albrecht H. Malaria in an inner-city hospital over a 12-year period. J Invest Med 2002; 50(1):147A. Presented at the Southern Section Meeting of the American Federation for Clinical Research, New Orleans, LA, February 2002
  

7. 
   Jodie Dionne-Odom, MD (Infectious Diseases Fellow and Fogarty Clinical Scholar, EUSM 2006 - 2009).
   

• 
  Currently she is an Assistant Professor of Medicine at Dartmouth-Hitchcock Medical Center
  

8. 
   Ameeta Kalokhe, MD (Infectious Diseases Fellow, EUSM 2008 - 20011).
   

• 
  Currently she is working on an analysis of intimate partner violence among HIV-infected patients in Project HOPE
  

9. 
   Nicholas Vogenthaler, MD, MPH (Infectious Diseases Fellow, EUSM 2006 - 2009).
   

• 
  Currently he is an Instructor in the Department of Medicine working on food insecurity among HIV-infected patients in Project HOPE
  

10. 
    Zandraetta Timms-Cook, MD, MPH (Infectious Diseases Fellow, EUSM 2008 - 2011).
    

• 
  Currently she is working on HIV prevention among African-American women in HPTN 064 as an HPTN Clinical Scholar
  

11. 
    Krutika Kuppalli, MD (Infectious Diseases Fellow and Fogarty Clinical Scholar, EUSM 2008 - 2011).
    

• 
  Currently she is working in India at YRG Care as a Fogarty Clinical Scholar. Dr. N. Kumarasamy and myself are her co-mentors
  

12. 
    Rupali Doshi, MD (Infectious Diseases Fellow, EUSM 2009 - 20012).
    

• 
  Currently she is working on an analysis of health service utilization and HAART use among HIV-infected patients in Project HOPE
  

13. 
    Sophia Hussen, MD, MPH (Infectious Diseases, EUSM 2010 – 2013)
    

• 
  Currently she is working on a study of stigma, norms and risk behaviors among black MSM in Atlanta in HPTN 061 as an HPTN Clinical Scholar
  

2. 
   Residency Program:
   

2. 
   Other:
   

Reginald Warren (class of 2000)

Ana Markovic (class of 2000) and Brent Kinder (class of 2000)

• 
  Markovic A, Kinder BW, del Rio C, Black CL, Tsavana N, Khechinashvili G, Blumberg HM. Prevalence and risk factors for testing tuberculin skin test (TST) positive in the Republic of Georgia. J Invest Med 1999; 47(2):116A. Presented at the Southern Section Meeting of the American Federation for Clinical Research, New Orleans, LA, January 1999.
  

• 
  Cherian S, Alexander LN, del Rio C, Horsburgh CR. Clinical Evaluation of American Thoracic Society (ATS) Criteria for Diagnosis of M avium complex (MAC) pneumonia. J. Invest Med 1998; 46(1):13A. Presented at the Southern Section Meeting of the American Federation for Clinical Research, New Orleans, LA, February 1998.
  

• 
  Wittkamp ML, del Rio C, Hunter M, Blumberg HM. Blood and body fluid exposure and post-exposure prophylaxis (PEP) among healthcare workers (HCW’s) at an urban medical center. J Invest Med 1999; 47(2):137A. Presented at the Southern Section Meeting of the American Federation for Clinical Research, New Orleans, LA, January 1999.
  

• 
  Birdwell K, Abrams C, Shevlin J, del Rio C. Improved outpatient care and outcomes among HIV-infected patients through a discharge intervention. J Invest Med 1999; 47(2):138A. Presented at the Southern Section Meeting of the American Federation for Clinical Research, New Orleans, LA, January 1999.
  

• 
  Hahn OM, Zimmer D, del Rio C, Ray SM. Incidence of nosocomial bloodstream infections by HIV status. J Invest Med 1999; 47(2):138A. Presented at the Southern Section Meeting of the American Federation for Clinical Research, New Orleans, LA, January 1999.
  

• 
  Ledoux D, Putgen A, del Rio C, Lennox JL, Lundberg B. The outcome of salvage antiretroviral regimens after HAART failure: impact of adherence. J. Invest Med 1999; 47(4):198A. Presented at the National Meeting of the American Federation for Medical Research, Washington DC, April 1999
  

• 
  Flip J, del Rio C, Lartsen N, Bock N, Blumberg HM. Risk of Mortality among a cohort of inner-city patients with tuberculosis. J Invest Med 2000; 48 (1):170A. Presented at the Southern Section Meeting of the American Federation for Clinical Research, New Orleans, LA, February 2000.
  

Day at EUSM and Adrian Puttgen (class of 2003)

• 
  Jarrell JA, Schevlin J, Sanchez M, Puttgen A, Lennox JL, del Rio C. Virological Outcomes and Compliance with Nelfinavir used in a BID vs. TID Dosing Schedule. Clin Infect Dis 2000; 31(1): 270. Presented at the 38^th Annual Meeting of the Infectious Diseases Society of America, New Orleans, LA, Sept 2000.
  

• 
  Bruce B, Blass M, Blumberg HM, Lennox J, del Rio C, Horsburgh CR. Risk of Cryptosporidium parvum transmission between hospital roommates. J Invest Med 2000; 48 (1):171A. Presented at the Southern Section Meeting of the American Federation for Clinical Research, New Orleans, LA, February 2000.
  
• 
  Bruce BB, Blass MA, Blumberg HM, Lennox JL, del Rio C, Horsburgh CR. Risk of Cryptosporidium parvum Transmission between Hospital Roommates. Clin Infect Dis 2000; 31:947-50.
  

• 
  Baker JC, Shubladze N, Tsertsvadze T, Khechinashvilli G, del Rio C, Blumberg HM. Seroprevalence of HIV and HCV infection among patients with tuberculosis in the Republic of Georgia. J Invest Med 2001; Presented at the Southern Section Meeting of the American Federation for Clinical Research, New Orleans, LA, March 2001
  

Winonah Wood (class of 2003)

Joseph Browning (class of 2004) and Tiffany (class of 2004)

• 
  Folch E, Hernandez I, Browning J, Vetter T, del Rio C, Lennox J. AIDS Related Mortality: Improved Survival with HAART but Causes of Death Unchanged. Presented at the 9^th Conference on Retroviruses and Opportunistic Infections. Seattle, WA, Feb 2002 (Abstract #756-W)
  
• 
  Browning J, Vetter T, Folch E, Hernandez I, del Rio C, Lennox J. Pre and Post-HAART: mortality reduced but causes unchanged. J Invest Med 2002; 50(1):145A. Presented at the Southern Section Meeting of the American Federation for Clinical Research, New Orleans, LA, February 2002
  

14. 
    Richards DC, Mikiashvilli T, Parris JJ, Shubladze N, Tsertsvadze T, Khechinashvili G, del Rio C, Blumberg HM. Risk of Hepatitis C virus (HCV) and HIV Co-infection among Tuberculosis patients in the Republic of Georgia. J Invest Med 2002; 50(1):146A. Presented at the Southern Section Meeting of the American Federation for Clinical Research, New Orleans, LA, February 2002.
    

Kiran Valini (class of 2011), Jessica Cohen (class of 2011) and Alana Stone (class of 2011)

• 
  Valini K, Vogenthaler N, Bell C, et al. Correlates of Self-disclosure of HIV serostatus among hospitalized HIV-positive crack cocaine users. J Invest Med 2011; 59(2):523. Presented at the Southern Section Meeting of the American Federation for Clinical Research, New Orleans, LA, February 2011
  
• 
  Cohen JL, Vogenthaler N, del Rio C, et al. The transition center: evaluation of an integrated care model for those with AIDS, serious mental illness and substance abuse disorders. J Invest Med 2011; 59(2):521-222 Presented at the Southern Section Meeting of the American Federation for Clinical Research, New Orleans, LA, February 2011
  
• 
  Stone A, Malebranche D, del Rio C. Fatherlessness and HIV risk-related behavior among black men. J Invest Med 2011; 59(2):523-54. Presented at the Southern Section Meeting of the American Federation for Clinical Research, New Orleans, LA, February 2011
  

Frances Priddy, MD, MPH – Assistant Professor of Medicine

Loida E. Bonney, MD, MPH – Mentor on an HIVMA Minority Clinical Fellowship Award (2007-08) and an ACTG minority HIV investigator program recipient (2011-2012)

Paula Frew, MPH, PhD – Assistant Professor of Medicine

Julie Hollberg, MD –Instructor in the Department of Medicine

Nicholas Vogenthaler, MD, MPH – Assistant Professor of Medicine and Global Health

1. 
   “Treatment is Prevention: novel approaches to HIV therapy”, Key Note Speaker, AIDS United Access to Care Grantee Meeting, Atlanta, GA April 5, 2012.
   
2. 
   “The Future of HIV Prevention”, Key Note Speaker at the 5^th Research Meeting on HIV/AIDS diagnosis, care and prevention among vulnerable populations. Mexico City, Mexico. November 14, 2011
   
3. 
   “History of HIV/AIDS in the US”, Speaker at the 2011 American Conference for the Treatment of HIV (ACTHIV). Denver, CO. April 7, 2011.
   
4. 
   “Building on Success”. Speaker at the CDC World AIDS Day Event. Atlanta, GA. December 1, 2010
   
5. 
   Invited Keynote speaker: “Evidence Based Global Health”. Annual Meeting of the Mexican National Epidemiological Surveillance System (Reunion Nacional del Sistema Nacional de Vigilancia Epidemiologica). Cancun, Mex. November 22, 2010
   
6. 
   Invited Keynote address: “Recent Advances in Biomedical HIV Prevention: Translating Research into Practice”. 5^th National Scientific Meeting of the CFAR’s Social and Behavioral Sciences Research Network. Atlanta, GA. October 8, 2010
   
7. 
   “14^th Annual Paul J. Galkin Lectureship” Brown University, Providence, RI. September 20-21, 2010.
   
8. 
   “University of Massachusetts Center for Global Health visiting Professor” University of Massachusetts, Worchester, MA. May 19, 2010
   
9. 
   “Facilitators and Barriers to HIV testing in hospital and other ambulatory care settings”. Presentation to the Institute of Medicine Workshop to identify facilitators and barriers to HIV testing. Washington DC. April 15, 2010.
   
10. 
    “Tim Gills Visiting Professorship” University of Colorado at Denver Center for AIDS Research, Denver CO. March 30-31, 2010.
    
11. 
    “Viral Zip Codes: Novel Influenza A (H1N1): what have we learned in the last 6 months? Invited speaker at the Fifth Annual National Symposium on Predictive Health “Human Health: Molecules to Mankind”. Atlanta, GA. December 14, 2009
    
12. 
    “Public Health and Health Care: Working Together for HIV Prevention”. Discussant in CDC Panel for World AIDS Day. Atlanta, GA. December 1, 2009
    
13. 
    “The Healthcare needs of Migrants. Key Note Speaker at the Hispanic Health Coalition of Georgia Latino Health Summit. Atlanta, GA. February 27, 2009.
    
14. 
    “Challenges in improving the National Response to the HIV/AIDS Epidemic”. Invited Speaker at the Seminar organized by the Instituto Nacional de Salud Publica and the Secretaria de Salud, Mexico. February 20, 2009
    
15. 
    “Challenges and Controversies in Infectious Diseases in the XXI Century”. Invited Lecture at the XXI Annual Meeting of the Medical Society of Hospital Angeles, Mexico City, Mex. February 19, 2009
    
16. 
    “Antiretroviral Therapy: 25 years of Progress”. Medical Grand Rounds, SUNY Downstate Medical Center, Brooklyn NY. December 11, 2008
    
17. 
    “Confronting the Global HIV epidemic: moving forward after Mexico City”. Invited key note speaker to the Second Annual International; HIV/AIDS Research Day of the UCSD CFAR. San Diego, CA. October 7, 2008
    
18. 
    “In the Eye of the Storm: the Emerging Epidemics of HIV, Hepatitis and Tuberculosis in the Former Soviet Republic of the Caucasus”. Invited Global Health Institute seminar speaker, University of North Carolina, Chapel Hill, NC. December 8, 2007.
    
19. 
    “Strategies for Initial Antiretroviral Therapy through Complicated Failure: A Case-Based Discussion”. Lecture presented at the Annual IAS-USA Course Improving the Management of HIV Disease. New York, NY. October 19, 2007
    
20. 
    “New Antiretrovirals”. Lecture presented at the Annual IAS-USA Course Improving the Management of HIV Disease. Washington, DC. May 23, 2007.
    
21. 
    “Antiretroviral Therapy Failure: A case based discussion”. Lecture presented at the Annual IAS-USA Course Improving the Management of HIV disease. Atlanta, GA. April 27, 2007.
    
22. 
    “The Perfect Storm: Emerging Epidemics of HIV, HCV and TB in the Republics of the Former Soviet Union”. Invited Lecture in the course: AIDS: A Multidisciplinary Approach” at the University of Washington. Seattle, WA. April 2, 2007
    
23. 
    “Strategies for Recruitment of Minority Study Participants”. Invited lecture presented at the symposium “Ethics in Action: Building Trust and Effectiveness in the Clinical Trial Process – Are we doing our best? Organized by the Emory University School of Medicine Clinical Trials Office and the Emory Center for Ethics. Atlanta, GA. March 1, 2006.
    
24. 
    “Antiretroviral Therapy in the Treatment Experienced Patient”. Lecture Presented at the 13^th Annual IAS-USA Current challenges in HIV disease. New York, NY. October 17, 2005.
    
25. 
    “Update in HIV infection”. Lecture presented at the Northside Hospital Internal Medicine Conference. Atlanta, GA. September 8, 2005.
    
26. 
    “Strategies for Providing Care to Hard to Reach Populations”. Invited Lecture and visiting Professorship at the University of North Carolina, Chapel Hill, NC. June 9 -10, 2005.
    
27. 
    “Disparities in HIV Epidemiology and Prevention”. Invited lecture presented at the 2004 Workshop on Disparities in the HIV Epidemic organized by the Vanderbilt/Meharry CFAR. Nashville, TN. Nov 18, 2004.
    
28. 
    “Changing the Paradigm on HIV testing”. Invited lecture during the 4^th Annual Harvard Medical School Centers for AIDS Research Symposium. Boston, MA. June 16, 2004.
    
29. 
    “West Nile Update” Invited lecture presented at the GeoSentinel Site Directors’ Meeting, Stone Mountain, GA. June 7, 2004.
    
30. 
    “Incorporating HIV Prevention to the Medical Care of Persons with HIV/AIDS”. Lecture presented during the 3^rd HIV Care in the Rural Southeast Conference. Amelia Island, FL. May 21, 2004.
    
31. 
    “The General Internist response to the threat of Bioterrorism and Emerging Infections: What you should know, why you should know it and how to keep up to date”. Workshop and Lecture presented at the Society of General Internal Medicine Annual Meeting. Chicago, IL. May 15, 2004
    
32. 
    “The Epidemiology of HIV/AIDS in Latin America compared to other countries around the world”. Visiting Professor, Duke University’s Center for International Studies. April 28-29, 2004.
    
33. 
    “Global Access to HIV/AIDS Treatment”. Lecture presented at the Town Meeting and Panel Debate organized by the Emory Global Health Organization. Atlanta, GA. April 15, 2004
    
34. 
    “Old and Emerging Infectious Threats: From Smallpox to Monkey Pox to SARS”. Emory Great Teachers Lecture Series. Atlanta, GA. April 15, 2004
    
35. 
    “Grants from the perspective of a reviewer”. Lecture presented during the workshop entitled “Bridging the Career Gap for Underrepresented Minority Research Scientists” organized by the NIAID/NIH. Bethesda, MD. November 6, 2003.
    
36. 
    “Viral Infections in Nephrology Patients”. Lecture presented at the Annual Georgia National Kidney Foundation Update Meeting, Sea Island, GA. September 5, 2003.
    
37. 
    “New Challenges in HIV Care”. Lecture Presented at the 6^th Annual Ryan White CARE Act Clinical Conference for Title I, II, III and IV Grantees. Orlando, FL. June 19, 2003.
    
38. 
    “HIV/AIDS in the Caribbean and Latin America”. Lecture Presented at the 11^th Annual IAS-USA Improving the Management of HIV Disease Conference, New York City, NY. March 28, 2003.
    
39. 
    “Prevention Among HIV-Seropositives”. Lecture Presented at the IAS-USA Improving the Management of HIV Disease Conference, Atlanta, GA. March 20, 2003.
    
40. 
    Visiting Professor, Boston VA Healthcare System, West Roxbury, MA. February 2003.
    
41. 
    “Smallpox Vaccination and its Complications” Department of Family and Preventive Medicine Seminar, EUSM. Atlanta, GA. February 28, 2003
    
42. 
    “New Advances in the Treatment of HIV/AIDS”. Lecture Presented at the 2^nd Annual Primary Care Conference. Atlanta, GA. October-November 2002.
    
43. 
    “HIV and Diseases of Tropical America”. Lecture Presented at the Conference “Medical Management of HIV in the Rural Southeast”. Lake Lanier, GA. October 2002.
    
44. 
    “An Ounce of Prevention: Reshaping Communities for a Safe, Healthy Metro Atlanta”. Lecture presented at the Regional Leadership Foundation Symposium, Atlanta, GA. April 18, 2002.
    
45. 
    “The Health Care Needs of Immigrants”. Lecture presented at the “Annual Women and their Health Conference”. Lake Lanier, GA. May 10, 2002.
    
46. 
    “Smallpox and other agents of Bioterrorism” Department of Family and Preventive Medicine Seminar, EUSM. Atlanta, GA. June 11, 2002.
    
47. 
    “HIV/AIDS as a Public Health Problem in the Americas”. Lecture Presented at the Symposium “Pan American Health in the 21^st Century: Strengthening International Cooperation and Development of Human Capital”. Cancun, Mex. December, 2001.
    
48. 
    “Bioterrorism” (Keynote speaker); Annual Meeting of the Asociación Peninsular de Infectología y Microbiología Clínica. Mérida, Mex. December, 2001.
    
49. 
    Seminar: “State of the Art on HIV Infection”; Presented during the XLVII Jornadas Médicas, Asociación de Médicos del Hospital Infantil de México, A.C. Puerto Vallarta, Mex. November 2001.
    

• 
  “View from a Study Section Member”. Lecture presented at the NIH/NIAID 5^th Bridging the Career Gap for Underrepresented Minority Scientists Seminar. Bethesda, MD. October 2001.
  
• 
  “Anthrax and Other Aspects of Bioterrorism”. Department of Family and Preventive Medicine Seminar, EUSM. Atlanta, GA. October 2001.
  
• 
  “HIV/AIDS and the International Picture”; 3^rd Annual Conference of the Association of Nurses in AIDS Care. Atlanta, GA. September 2001.
  
• 
  “HIV Care in the Inner-City”. Medical Grand Rounds. Crawford W Long Hospital. Atlanta, GA. September 2001.
  
• 
  “HIV Care for the Urban Poor”. Lecture presented at the Conference on HIV/AIDS Care in Safety Net Systems: Current and Future Challenges. Santa Fe, New Mexico. June 2001
  
• 
  “Antiretroviral Therapy for HIV Infection”. Lecture Presented at the X Congreso de la Asociación Panamericana de Infectología. Guadalajara, Mex. May 2001.
  
• 
  “Internet Resources for HIV Providers”. Lecture presented at the Conference on HIV Management in the Rural Southeast. Callaway Gardens, GA. April 2001.
  
• 
  “What I learned in the last Eleven Years”. Medical Grand Rounds Crawford W Long Hospital. Atlanta, GA. November 2000.
  
• 
  “Pneumocystis carinii: Epidemiology and Clinical characteristics”. Lecture presented at HIV Infection and AIDS: An update on Clinical-Pathologic Issues in the Diagnosis of Indicator Conditions. Armed Forces Institute of Pathology, Washington, DC. August 2000.
  

• 
  “How Should we Spend our Prevention Dollars?. Invited Speaker to the 20^th Conference on Retroviruses and Opportunisitic Infections (CROI). Atlanta, GA March 3 – 6, 2013
  
• 
  “Opportunisitic Infections in Patients with HIV Infection” and “The Pregnant Patient with HIV”. Invited Speaker at the 39^th Remington Winter Course in Infectious Diseases. Beaver Creek, CO. February 10 – 15, 2013
  
• 
  “The Importance and Implications of Antibiotic Resistance for the Clinician”. Keynote Speaker at the VII Congreso Grupo Angeles. Mexico City, Mex. Oct 25 – 27, 2012.
  
• 
  “Adherance and Retention in Care”. Invited Speaker to the AWACC (Annual Workshop on Advanced Clinical Care) – AIDS 2012 Conference. Durban, South Africa. October 5, 2012.
  
• 
  “Antiretroviral Therapy as Prevention: A Debate on the Role of ART as Prevention in Clinical Practice”. Open Plenary Speaker at the 2012 American Conference for the Treatment of HIV (ACTHIV), Denver, CO. May 10 -12, 2012,
  
• 
  “Aging and HIV: Update from CROI”. Invited Speaker at the 5^th International Course HIV: Pathogenesis, Prevention and Treatment. Lima, Peru. March 23 – 24, 2012.
  
• 
  “Neurological Complications of HIV Infection” and “Clinical Spectrum of Acute Retrovirus Syndrome”. Invited Speaker at the 37^th Remington Winter Course in Infectious Diseases. Snowmass, CO. February 6 – 11, 2011
  
• 
  “Retention in Care”. Invited Speaker at the 48^th Annual Meeting of the Infectious Diseases Society of America Vancouver, Canada. October 21-24, 2010
  
• 
  “HIV infection – beginning HAART” and “HIV infection – Managing opportunistic infections”. Invited Speaker at the 36^th Remington Winter Course in Infectious Diseases. Vail, CO. February 21 – 26, 2010
  
• 
  “HIV Prevention among hard to reach populations”. United States-Russia Workshop on HIV Prevention Science organized by the Office of AIDS Research. Moscow, Russia. October 28 – 30, 2009.
  
• 
  “The role of Integrease inhibitors in the treatment of HIV infection”. Invited speaker at the 9^th International Symposium of the Mexican Association of HIV Providers (AMMVIH). Cancun, Mex. November 22, 2008
  
• 
  “Current Issues and Controversies in HIV Infection Management” Invited panelist to an Interactive Symposium at the 48^th Annual ICAAC/46^th Annual IDSA. Washington, DC. October 27, 2008
  

• 
  “HIV, STDs and the Global AIDS Pandemic: Lethal Synergy 2008” Invited panelist to an Interactive Symposium at the 48^th Annual ICAAC/46^th Annual IDSA. Washington, DC. October 28, 2008
  
• 
  “Treating Tuberculosis in People Living with HIV”. Invited Plenary Speaker at the Second Eastern Europe and Central Asia AIDS Conference. Moscow, Russian Federation, May 3 – 5, 2008.
  
• 
  Poster discussant in the session “New approaches to HIV testing” at the 15^th Conference on Retroviruses and Opportunistic Infections (CROI). Boston, MA. February 4, 2008.
  
• 
  “New drugs and old challenges in AIDS”. Invited plenary speaker at the X Mexican National HIV/AIDS Meeting. Leon, Mex. December 1, 2007.
  
• 
  “The Metamorphosis of the HIV Epidemic”. Invited lecture presented at the XXIV National Congress of Biomedical Research in Mexico. Monterrey, NL. Mex. Aug 30, 2007
  
• 
  “Management of HIV Infection”. Invited panelist to an Interactive Symposium at the 44^th Annual Meeting of the Infectious Diseases Society of America. Toronto, Canada. October 13, 2006
  
• 
  “Yellow fever: New Challenges to an Old Scourge”. Invited lecture presented at the Annual Meeting of the Binford-Dammin Society of Infectious Disease Pathologists. Atlanta, GA. February 12, 2006.
  
• 
  “Antiretroviral Therapy and its impact on Public Health”. Invited speaker at the XI National Public Health Congress. Cuernavaca, Mex. March 2, 2005.
  
• 
  “Screening for HIV in Emergency Departments”. Invited lecture presented at the 2005 National HIV Prevention Conference. Atlanta, GA. June 13, 2005.
  
• 
  “Impact of Recent Biomedical Advances on Current HIV Prevention Approaches”. Invited plenary speaker to the 2003 National HIV Prevention Conference. Atlanta, GA, July 27-30, 2003
  
• 
  “Internal Medicine Update: What’s new in Infectious Diseases”? American College of Physicians/American Society for Internal Medicine. Georgia Chapter Meeting, Savannah, GA. March 2003.
  
• 
  “West Nile Infection in Patients with HIV/AIDS”. Invited lecture, presented at the “West Nile Virus: Addressing a Regional Crisis” Conference, Southeastern Center for Emerging Biological Threats. Atlanta, GA. January 14-15, 2003.
  
• 
  “Advances in Treatment of HIV/AIDS”. Invited Plenary Lecture, presented at the 8^th National HIV/AIDS and STI Congress, Veracruz, Mexico. December 5, 2002.
  

• 
  “The Terror of Emerging Infections, the Promise of New Vaccines”. Invited speaker at the 25^th National Meeting of the Society of General Internal Medicine. Atlanta, GA. May 2002.
  
• 
  “The Perilous Road from Detection to Undetectable: HIV in the Inner City”. Invited speaker at the 8^th Conference on Retrovirus and Opportunistic Infections. Chicago, IL February 2001.
  
• 
  “Implication and Consequences of non-adherence to Antiretroviral Treatment”. Invited speaker at the Latin America and the Caribbean STD/AIDS Foro 2000. Rio de Janeiro, Brazil. November 2000
  
• 
  “Access to ARV’s in Developing Countries”. Invited speaker at the 9^th International Congress on Infectious Diseases. Buenos Aires, Argentina. April 2000
  

• 
  State-of-the-Art lecture: “New Challenges in the Antiretroviral Management of HIV/AIDS”. Invited speaker at the Congreso Centroamericano de Enfermedades de Transmisión Sexual y SIDA. San Pedro Sula, Honduras. November 1999
  

• 
  “Infectious Diseases and Minorities: Issues and Concerns”. Invited speaker at the 99^th General Meeting of the American Society for Microbiology. Chicago, IL. June 1999.
  

a. Published and accepted research articles in refereed journals:

1. 
   Gallo S, Marin E, Ramírez A, del Río C, Elizondo J, Ramírez J. Colocación Endoscópica de Sondas para Alimentación Enteral. Rev. Gastroenterol Mex. 1984; 49(4): 247-50 [PMID 6442452].
   
2. 
   Guarner J, del Río C, Slade BA. Tuberculosis as a Manifestation of the Acquired Immunodeficiency Syndrome. JAMA 1986; 256(22):3092.[PMID 3783842]
   
3. 
   
   Directory: faculty -> resumes
   faculty -> Ralph R. Ferraro Chief, Satellite Climate Studies Branch, noaa/nesdis
   faculty -> Unit IV text: Types of Oil, Types of Prices Grammar: that/those of, with revision
   resumes -> Curriculum vitae
   resumes -> Current position
   resumes -> Matthew j. Strickland
   resumes -> Christine Lorraine Moe education
   resumes -> Curriculum Vitae Arthur L kellermann, M. D., M. P. H. Name
   resumes -> John Blevins, Th. D. August 13, 2012
   resumes -> June 2014 curriculum vitae
   resumes -> D., M. P. H. Page 1emory university school of medicine
   
   
   
   Download 271.92 Kb.
   
   Share with your friends: